Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move;
(TSXV: $VIVO.V)
(CSE: $DIXI_U.C) (NYSE: $ACB) (CSE: $CBIS.C) (CSE: $MYM.C)
Delta, Kelowna, BC – April
25, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/04251VIVO-DIXI-ACB-CBIS-MYM.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to the 200th episode of Investorideas.com “potcast”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
As
this is our 200th episode we’d like to thank all of our interview guests who
have come on before and of course you the listeners for sticking around this
long. As we’ve reached this milestone I’m happy to announce that we will soon
be adding new features such as product reviews and video interviews along with
our continued daily announcements and interviews. If you’re working in the
cannabis industry, no matter how big or small the role, please get in touch
with us so we can help share your story and give our audience more ideas worth
investing in.
Today
we are looking at announcements from VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQB: VVCIF), Dixie Brands (CSE: DIXI.U), (OTC: DXBRF), Aurora Cannabis
Inc. (NYSE: ACB) (TSX: ACB), Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF), Cannabis One
Holdings Inc. (CSE:CBIS) and MYM
Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF).
VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQB: VVCIF) today announced that its wholly-owned subsidiary, Canna
Farms Limited, has received local municipal approval for its Phase 5 expansion
which will add an incremental 2,500 kilograms of indoor capacity to its
facility in Hope, B.C.
Canna
Farms' Phase 5 expansion, originally slated to begin construction in 2020, is
now expected to be completed in late 2019 or early 2020, pending regulatory
approval. The expansion consists of 10,000 square feet of cultivation space,
with expected capital costs of $3.5 million and is expected to bring VIVO's
total internal production capacity to 13,500 kilograms by early 2020.
"Canna
Farms is a cultivator and purveyor of premium quality, award winning,
small-batch craft cannabis with widespread recognition and appeal as evidenced
by its award for 'Top Reviewed Licensed Producer of the Year' at the 2018
Canadian Cannabis Awards," said Barry Fishman, Chief Executive Officer of
VIVO. "This expansion will further
increase Canna Farms' production capacity to help meet the significant market
demand for premium B.C. dry bud. This project represents a strategic deployment
of a minor portion of our strong cash position as the Company continues to
invest to drive future growth."
Dixie Brands (CSE:
DIXI.U), (OTC:
DXBRF), one of the cannabis industry's leading
consumer packaged goods companies, today
announces a partnership with FounderMade to exclusively host the "Future of CBD &
Cannabis" lounge at the FounderMade Discovery Show in New York City this coming June. Renowned for creating
an environment where bold, innovative, life-changing products can thrive, the
FounderMade Discovery Show is a summit for next generation companies to
showcase groundbreaking products to key industry players.
A pioneer in the category for the past
ten years, Dixie's Future of CBD & Cannabis lounge will champion the
cannabis plant and spotlight the industry as it emerges from prohibition and
enters the mainstream. As part of the showcase, Dixie will provide hands-on
experiences and educate attendees on its full portfolio of THC and CBD-infused
products, including hemp-derived CBD cosmeceutical brand, Kuida™, developed to
bring the benefits of CBD to a comprehensive portfolio of skin and body care
products for women. Once approved by the regulatory authorities, Kuida will be
launched stateside via an exclusive distribution partnership between Dixie and
Khiron Life Sciences, subject to TSX approval.
At the Future of CBD & Cannabis
lounge, in addition to learning about Dixie's robust portfolio of Dixie Brands
THC and CBD-infused products, event attendees will have the opportunity to
engage with Aceso™ Hemp, Dixie's growing line of indication-specific, hemp-derived
supplements that promote optimal health. As one of the first entrants into the
category, Aceso Hemp brings a deep understanding of the industry's complex
regulatory structure and expertise in the production of safe, effective and
compliant products that can be sold across the United States.
Aurora Cannabis Inc. (NYSE:
ACB) (TSX:
ACB), announced
today that the company has signed a binding
share purchase agreement whereby Aurora has acquired all of the issued and
outstanding common shares of privately-held Chemi Pharmaceutical Inc., an Ontario-based laboratory specialized in providing high quality
analytics services to the pharmaceutical and cannabis industries, in a cash and
share transaction comprised of an undisclosed cash payment and share
consideration of 83,299 shares paid on closing and 41,649 payable upon
achievement of certain Chemi milestones.
Chemi has a Health Canada Drug
Establishment Licence enabling them to perform certified GMP compliant quality
control analytical testing. In addition, Chemi has received US FDA
accreditation for their facility, which is the gold standard for global
pharmaceutical testing. Acquiring Chemi with their Drug Establishment Licence
provides a critical prerequisite for applying for a Cannabis Drug Licence,
which is required for the development of cannabis therapies within the global
medical cannabis market.
Strategically located adjacent to Pearson
Airport in Mississauga, Ontario, Chemi provides specialized cannabis testing
across a broad set of parameters, including cannabinoid and terpene content.
Chemi will be integrated into the Company's wholly owned subsidiary, Anandia
Laboratories Inc. ("Anandia"), expanding Anandia's leading analytics
capabilities to meet client demand and diversifying its specialized testing
services for both the medical and the upcoming edible and derivatives markets.
Following the acquisition of Anandia in
August 2018, Aurora integrated Anandia's plant science operations into the
Company's broader science team, enabling Anandia to maintain independence as an
analytical service provider, with its operations run at arm's length to ensure
client confidentiality.
As the Canadian cannabis industry
matures, the cultivation and processing operations of licensed producers,
including Aurora, have developed rapidly to meet the growing demand from
medical patients and consumers alike. Expanding Anandia's analytical testing
footprint will enable it to service a broader base of domestic and
international clients while ensuring continued timelines and quality of its
testing services for existing clients.
Valens GroWorks Corp. (CSE:
VGW) (OTC:
VGWCF), a multi-licensed, vertically
integrated provider of cannabis products and services focused on various
proprietary extraction methodologies, distillation, cannabinoid isolation and
purification, as well as associated quality testing announced that
it has entered into an arm's length binding multi-year extraction services
agreement to provide cannabis and hemp extraction services to HEXO Corp (TSX:
HEXO) (NYSE-A:
HEXO), a leading cannabis producer and consumer
packaged goods cannabis company.
The Agreement has an initial 2-year term
from the date of the first shipment, with HEXO supplying Valens with an annual
minimum of 30,000kg in the first year and 50,000kg in the second year of
cannabis and hemp biomass. Valens will process this material on a fee for
service basis into premium quality resins and distillates using the Company's
leading proprietary extraction processing methods. The Agreement contains
provisions under which it may be terminated with 90 days written notice after
the one-year anniversary. Valens expects to receive and begin processing the
first shipment from HEXO early in Q3 of 2019 and currently holds all required
licensing from Health Canada to carry out its obligations under the Agreement.
Cannabis One Holdings Inc. (CSE:CBIS), an emerging, premier "House of
Brands" in North America, announced that
it has entered into a letter agreement with Colorado-based cannabis industry
consulting firm Itachi Advisory Group LLC, to pursue acquisitions related to a
suite of portfolio assets related to cannabis retail, cultivation, and
manufacturing operations from certain entities advised by Itachi.
On execution of the Agreement, Jeffery
Mascio, CEO of Cannabis One, stated, "We believe this new partnership with
Itachi will provide CBIS with a profound opportunity to explore the acquisition
of a series of accretive transactions designed to rapidly expand our
cannabis-related infrastructure." Mr. Mascio continued, "We believe
that Neil Demers and his team at Itachi have identified a host of attractive
assets for Cannabis One to consider and we look forward to evaluating each
opportunity independently, on its merits, but with the express intention of
moving towards a definitive agreement with each party as quickly as may be
practicable."
MYM Nutraceuticals Inc. (CSE:
MYM) (OTCBB:
MYMMF). announced the
formation of a Nevada Company, MYM One World LLC, to facilitate the joint
multi-year co-operative agreement between MYM and Aqueous Sciences, a
subsidiary of One World Ventures Inc. The company's mandate is to cultivate,
extract & distribute 3,000 acres of hemp on Navajo Nation land located near
the four corners area of Colorado, Arizona, Utah and New Mexico, USA.
The purpose of organizing a new company
to cultivate, extract, and distribute hemp is so each corporation will own 50%.
MYM and Aqueous also plan to extend their activities to include the extraction,
manufacture and distribution of hemp based products that will comply with
Navajo Nation, USDA, FDA and FTC regulations and requirements.
"Our partnership with Aqueous to
cultivate 3,000 acres of CBD-rich hemp has taken another step forward today
with the formation of MYM One World LLC," said Howard Steinberg, CEO of
MYM. "Our team is currently preparing the fields for the 2019 growing
season. We're looking forward to exceeding the results of last year's test crop
that was successful in growing an abundance of CBD-rich hemp."
Lastly if you happen to be in the Toronto
area, O'Cannabiz, Canada's
leading business-focused cannabis conference and expo,
kicks off today at Toronto's International Centre with a
powerful opening keynote from rocker-turned-cannabis advocate Henry Rollins.
Tune in tomorrow for more cannabis news,
as well as a special piece on 420 and my interview with Dooma Wenschuh,
Co-Founder and CEO of Province Brands where we discuss cannabis beverages and
what we can expect to see regarding regulations in Canada this October.
Investorideas also wishes to mention that starting next
week we will be starting our CleanTech
and Climate Change Podcast to help bring more ideas worth investing in.
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment